PDF Archive search engine
Last database update: 12 August at 05:10 - Around 220000 files indexed.
Results for «tumours»:
Total: 100 results - 0.046 seconds
Virtually all these tumours are adenocarcinomas, while about 10% comprise squamous cell tumours.
The majority of these tumours are adenocarcinomas, Check This Out while about 10% comprise squamous cell tumours.
Moreover, with its rapid growth, tumours require various nutrients and vitamins in order to overexpress a variety of tumour-specific receptors that are potential targets for DDSs radiopharmaceuticals.
In our Institute PET/CT images are used for detecting, staging and monitoring various malignant tumours.
The liver is also a common metastatic site for tumours in organs drained by the portal vein such as from colorectal, pancreatic and stomach malignancies .
Pathology Sub Editor of “The Breast” (1991-2011) Editorial Board of “Analytic Cellular Pathology” (1992-1999) Editorial Board of “Cytopathology” (1994-2005) Editorial Advisory Board of “Current Diagnostic Pathology”(1994-present) Editorial Board of “Advances in Anatomic Pathology” (2000-present) Editorial Board of Endocrine related cancer (2001-present) Editorial Board of “Histopathology” (2002-present) Editorial Advisory Panel of Future Oncology (2004-present) Editorial Board of “Journal of Pathology” (2007-present) Selected publications Curtis C et al The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Mathematical Modeling in Hematopoiesis 1 Postgraduate career since 2016 Professor (10%) of Medicine, University of Bergen, Norway since 2015 Member of the Executive Board of the University Cancer Center Hamburg – Hubertus Wald Tumor Center since 06/2002 Director of the new Institute of Tumor Biology, Full Professor (C4) of Medicine, University Hospital Eppendorf (UKE), University of Hamburg, Germany since 2002 Coordinator of the Oncology Research Program at UKE 09/2002 – 08/2008 Deputy Director of the new Center of Experimental Medicine, UKE 01/1999 – 05/2002 Professor (C3) in Molecular Genetics, Department of Gynecology and Obstetrics, University Hospital Eppendorf, University of Hamburg, Germany Head of Molecular Oncology, Department of Gynecology and Obstetrics, University Hospital Eppendorf, University of Hamburg, Germany 07/1995 – 12/1998 Associate Professor (“Privatdozent”), Institute of Immunology, LudwigMaximilians-University, Munich, Germany 06/1989 – 12/1998 Research Scientist, Head, Micrometastasis Research Laboratory, Institute for Immunology, Ludwig-Maximilians-University, Munich, Germany Head, Project Group “Early metastasis of epithelial tumours”, Tumor Centre Munich, Germany Scientific Head of the Animal Care Unit, Institute of Immunology 05/1987 – 05/1989 Postdoctoral DFG-Fellow , Research Associate, Division of Hematology and Oncology, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI, USA 06/1986 – 04/1987 Research Associate, Department of Biostatistics, Medical Institute of Environmental Hygiene, Düsseldorf, Germany Editorial and Publishing Activities Cancer Research, Clinical Cancer Research, British Journal of Cancer, Molecular Oncology, Breast Cancer Research Selected Professional Memberships:
Bevacizumab, a monoclonal antibody against vascular endothelial growth factor, is one of the most extensively studied targeted agents and has demonstrated significant clinical benefits in several solid tumours, including breast cancer.
ABOUT NMDARE 87%
What is known is that most tumours associated with anti-NMDA receptor encephalitis contain neural tissue (tissue containing cells identical to that found in the brain), and NMDA receptors.
Brain Tumours MR is firmly established as a diagnostic and assessment method of choice for brain tumour patients and has found increasing use as a cancer imaging biomarker [33-35].
The reduced curability of hypoxic tumours by radiotherapy is one of consequent challenges, but their hypoxia also offers unique, exploitable properties.
Since the conception of JDIT in the latter part of 2014, we have had the pleasure to receive a variety of research articles, reviews, commentaries, perspectives and case reports ranging from topics on the use of PET imaging, automated radiosynthesis, 18F-FES-PET/CT imaging of breast cancer, prostate cancer therapy and imaging, PET/CT imaging of neuroendocrine tumours using 68Ga-somatostatin analogues, targeted radionuclide therapy, transcranial sonography applications for movement disorders, the application of 18F-fluoride as a marker of unstable atheroma and the use of radionuclides in diagnostic imaging and therapy.
The application of peptide receptor radionuclide therapy (PRRT) based on radiolabelled somatostatin analogues have produced encouraging results in various somatostatin receptor positive tumours.
· Frequent customers of cell phones don't have the threat of obtaining cancer or non malignant tumours, than those who make use of the phones rarely.
These are currently being used to define the cancer initiating cells in leukemia’s and solid tumours and the process of transcriptome evolution in cancer development.
Antibody drug1 75%
With the success of Kadcyla against solid tumours comes the real promise of ADCs in tackling the most aggressive and resistant tumours with the worst clinical outcomes.
In cancer, nucleoside transporters have an important role in maintaining the hyperproliferative state of tumours and are important targets for diagnostic and therapeutic agents in the detection, treatment and monitoring of cancers.